OneCompress Bamboo Footsleeves — A Thirty-Day Trial of the Slip-On Foot Sleeve, the Six Conditions It Markets For, and What the 60-Day Guarantee Actually Looks Like

An editorial look at the slip-on bamboo footsleeve from OneCompress — the material, who the brand says it's for, the three things it will not do, and what thirty days of daily wear actually looked like.

Elena Marsh · Staff Writer

Published Oct 13, 2026Reviewed by our editorial standards team18 min read

Disclosure. This review is sponsored and contains affiliate links. We may earn a commission on orders placed through the links below at no extra cost to the reader. Our editorial standards and the full affiliate disclosure are posted at the links in the footer. Prices and promotions reflect the manufacturer's current list on onecompress.com at the time of writing and are subject to change.†

A hand pulling the bamboo footsleeve over the ankle — the strapless slip-on style the review is built around — The sleeve pulls on without straps, Velcro, or fasteners — the single design decision the brand repeats most often in its own material.

Three things are worth knowing before any review of a $49 foot sleeve is worth a reader's attention. The first: there is a real condition behind the search queries that bring most adults to a page like this one. Peripheral neuropathy affects roughly 20 million adults in the United States, and a significant share of those readers have arrived here because the tingling, numbness, or persistent discomfort in their feet has become something they think about every day.^[1]†

The second: no slip-on sleeve, including this one, treats, cures, or reverses neuropathy. The statements made about the OneCompress Bamboo Footsleeves — and about any device like it — have not been evaluated by the Food and Drug Administration. The product is not intended to diagnose, treat, cure, or prevent any disease.† A sleeve is a comfort device. The honest question is whether this particular comfort device is better, worse, or roughly equivalent to the alternatives already in a drawer somewhere in the reader's house.

The third: OneCompress has sold the sleeve to a reported 750,000+ customers and prints a 60-day risk-free money-back guarantee on its own storefront. That return policy — not the marketing copy — is the mechanism this review relies on when it recommends a thirty-day home trial.

The one-paragraph version, for a reader who stops here

The OneCompress Bamboo Footsleeves are a slip-on, strapless foot and ankle sleeve made from a bamboo-based fiber blend. The company markets them for all-day and overnight comfort across six foot-and-ankle conditions, including peripheral neuropathy, plantar fasciitis, and arthritis. They are not a medical device, do not deliver a labeled compression grade in mmHg, and will not reverse a diagnosed condition. For a reader looking for a comfortable, washable, easy-to-wear sleeve in the sub-$50 range and willing to use the 60-day guarantee as insurance, the format is a reasonable one to try. For a reader looking for a clinical-grade graduated-compression stocking, this is not that product and the honest answer is to ask a clinician for a prescription-grade option.†

Background · In plain EnglishWhat Peripheral Neuropathy Actually Is, and Why It Starts in the Feet

Before any paragraph about a wearable is worth a reader's attention, the condition it addresses is worth describing clearly. The term peripheral neuropathy covers damage to the nerves outside the brain and spinal cord — the long, insulated fibers that carry sensation from the skin, the muscles, and the organs back to the central nervous system, and that carry movement signals the other way. When those fibers are injured or deteriorate, the signals they carry become distorted, dropped, or amplified. What a reader feels, in practice, is one or more of a familiar set of sensations: tingling or "pins and needles," numbness, burning, electric-shock-like jolts, loss of balance, or sensitivity to light touch that previously felt normal.^[2]†

The feet are typically the first area affected for a specific anatomical reason: the nerves that reach the toes are the longest in the body, and the longest nerves are the most vulnerable to any process — metabolic, mechanical, nutritional, or toxic — that damages the myelin sheath or the axon itself. In clinical terminology this is called a length-dependent polyneuropathy, and the stocking-and-glove pattern it produces (sensation changes starting in the toes and progressing up the foot) is the single most common presentation primary-care clinicians see.

20M+

US adults estimated to live with some form of peripheral neuropathy

National Institute of Neurological Disorders and Stroke

50%

Of adults with diabetes who develop a form of diabetic peripheral neuropathy during their lifetime

American Diabetes Association

30–40%

Of patients receiving certain chemotherapy regimens who develop treatment-related neuropathy

Published oncology literature

~30%

Of neuropathy cases that remain idiopathic — no identified cause after workup

Peer-reviewed neurology reviews

Those figures are the reason the search queries that bring most adults to a page like this one are so uniform: a reader is looking up "tingling in my feet," "burning feet at night," or "numb toes" because something has changed, and the first instinct is to find a plain-English explanation before scheduling a clinic visit. The explanation above is that plain-English version. The next sections cover the four causes behind most of the cases, how clinicians classify what they are seeing, and the daily-life strategies with the strongest published evidence behind them.

The four most common causesWhere Most Peripheral Neuropathy Diagnoses Actually Come From

A workup for new foot sensation changes typically narrows the search to one of four buckets, in roughly the order below. The percentages are drawn from epidemiology reviews published in general-neurology and primary-care journals; a reader's own clinician will test for several of them in parallel.

60–70%

Diabetes-related

By a wide margin, the most common cause of peripheral neuropathy among US adults. Chronically elevated blood glucose damages the small blood vessels (vasa nervorum) that feed the peripheral nerves, and the nerves themselves through several biochemical pathways. Tight glycemic control is the single most consistently supported strategy for slowing progression.†

~10%

Chemotherapy-induced

Several classes of chemotherapy drugs — platinum compounds, taxanes, vinca alkaloids, and others — are known to cause a specific pattern of neuropathy. It can appear during treatment and persist afterward; dose adjustment and supportive care are managed by the oncology team.

~10%

Nutritional & toxic

Vitamin B12 deficiency, less commonly B1 or B6 excess, chronic heavy alcohol use, and exposure to certain heavy metals or industrial toxins are all documented causes. A basic blood panel typically catches B12 deficiency — a reversible cause, when treated early.

~30%

Idiopathic

Even after a thorough workup, roughly a third of cases do not land on a specific cause. "Idiopathic peripheral neuropathy" is a clinical diagnosis of exclusion. Management focuses on symptom relief and quality-of-life measures.

Percentages overlap and are approximate because a single patient may fall into more than one bucket (for example, diabetes and B12 deficiency); figures reflect general-population US reviews rather than any single study.

How clinicians classify itSmall Fiber, Large Fiber, Sensory, Motor, Autonomic — What the Terms Actually Mean

A reader who takes new foot symptoms to a clinic will likely hear terminology that is not self-explanatory. Below is a short glossary of the words that come up most often, written so a reader can follow the conversation that happens in the exam room rather than nod through it.

Small-fiber neuropathy: Damage to the thin, unmyelinated nerve fibers that carry pain and temperature. Produces burning, electric sensations, and sensitivity to light touch. Nerve-conduction tests often come back normal; diagnosis typically requires a skin biopsy.
Large-fiber neuropathy: Damage to the thicker, myelinated fibers that carry vibration sense, position sense, and motor signals. Produces numbness, loss of balance, weakness, and loss of reflexes. Shows up on nerve-conduction and EMG studies.
Sensory vs. motor: Sensory means the nerves carrying information in are affected (what you feel). Motor means the nerves carrying signals out are affected (how muscles move). Most peripheral neuropathy is primarily sensory; motor involvement generally comes later.
Autonomic involvement: The autonomic nervous system controls automatic functions — heart rate, digestion, bladder, sweating. When neuropathy affects these fibers, symptoms include lightheadedness on standing, altered sweating patterns, or digestive changes. This warrants its own workup.
Length-dependent pattern: The classic "stocking-and-glove" distribution: symptoms start in the toes, progress up the feet, and only reach the fingers later. This is the pattern diabetes and most metabolic neuropathies produce.

Day-to-day strategies with published evidenceFive Practical, Non-Prescription Steps That Appear Most Often in the Clinical Literature

A plain wooden kitchen table — the editorial setting for day-to-day strategy notes in this review — None of the strategies below is a replacement for a clinician's management of the underlying condition. They are the daily-life layer that sits beside it.

The strategies below are the ones that come up most consistently across neuropathy reviews written for both clinicians and patients. None of them is a cure. All of them are low-risk, low-cost, and widely available, which is why clinicians recommend them regardless of what else they prescribe.†

Tight glycemic control, for diabetes-related cases. The single most-studied intervention. Even modest, sustained improvements in HbA1c correlate with slower symptom progression. The specifics belong to the clinician who manages the diabetes.
Regular aerobic and resistance exercise. Multiple randomized trials in diabetic peripheral neuropathy populations show that supervised exercise programs — typically walking, stationary cycling, or light resistance training 3–5 times a week — are associated with improved nerve function and reduced pain scores at six months.
Vitamin B12 testing (and correction, when deficient). B12 deficiency is one of the few directly reversible causes. A simple serum B12 level, with methylmalonic acid as a confirmatory test, is a reasonable ask of any clinician evaluating new foot symptoms.
Daily foot inspection and well-fitting footwear. For readers with reduced sensation, the inspection step prevents the small cut or blister that goes unnoticed and becomes a larger problem. Shoes with a wide toe box, firm midsole, and no internal seams at the toes are what podiatrists recommend most often.
Physical therapy and balance training. Reduced sensation increases fall risk. A short course of PT focused on balance, gait, and lower-extremity strength is an evidence-supported layer that costs no more than a few visits typically covered by insurance.

What the evidence does not strongly support

A long list of over-the-counter supplements is marketed for peripheral neuropathy. The evidence base for most of them is thin, mixed, or confined to small studies. Alpha-lipoic acid is the one with the most published positive data (specifically for diabetic peripheral neuropathy, at ~600 mg/day in European trials), but even there the effect size is modest and US clinical guidelines treat it as adjunctive, not primary. A conversation with the clinician managing the condition is the right place to decide whether to add it.†

When to call the clinic the same dayRed Flags That Should Not Wait for the Next Scheduled Appointment

Most peripheral neuropathy progresses slowly, over months and years. A short list of symptoms, however, warrants a same-day call to a clinician rather than a watchful-waiting approach. These are the red flags published patient-education materials from major academic medical centers consistently list:

Call a clinician the same day if any of the following appears

Sudden onset of numbness, weakness, or paralysis in a limb, especially if it affects one side of the body — this can indicate a vascular event, not neuropathy.
Loss of bladder or bowel control, with or without back pain — a specific red flag for cauda equina syndrome, which is a surgical emergency.
Rapid progression of weakness over hours to days, especially ascending from the feet upward — can indicate Guillain-Barré syndrome.
An open wound, sore, or ulcer on the foot that is not healing — particularly for readers with diabetes, this is a same-day call, not a next-week visit.
New fever with any of the above, or a foot that is red, hot, and swollen in a focal area — can indicate infection in soft tissue or bone.
Severe, sudden-onset pain in one leg or foot, with coldness or color change — can indicate acute arterial insufficiency.

Three myths worth retiringCommon Beliefs the Published Evidence Does Not Support

Myth 1 · "If you have tingling in your feet, you have diabetes."

The claim: foot tingling is a diabetes symptom and nothing else needs to be considered.

While diabetes is the leading cause of peripheral neuropathy in the US, roughly one in three patients evaluated for new foot symptoms has a non-diabetic cause — B12 deficiency, autoimmune conditions, medication side effects, or an idiopathic process. A full workup, not an assumption, is the right path.

Myth 2 · "Neuropathy is just a nuisance; nothing to do about it."

The claim: once nerve symptoms start, there is no meaningful intervention and a patient should accept it.

Reversible causes exist (B12 deficiency, some medication effects). Even for non-reversible cases, controlling the underlying driver and layering the five day-to-day strategies above can slow progression and reduce symptoms meaningfully in many patients.

Myth 3 · "A compression sleeve will cure it."

The claim: an over-the-counter wearable can treat, reverse, or cure peripheral neuropathy.

No slip-on sleeve, including the OneCompress Bamboo Footsleeves reviewed below, treats, cures, or reverses any form of neuropathy. Wearables sit in the comfort-and-support category. Any product that claims otherwise is making a claim the FDA has not evaluated.†

What it is · The product itselfA Strapless Slip-On, Bamboo-Blended, Open-Toe Design

A pair of gray OneCompress Bamboo Footsleeves laid flat on a plain surface

A close-up of the bamboo fiber weave at the ankle cuff of the OneCompress sleeve

The product is a seamless, open-toe foot-and-ankle sleeve manufactured from a bamboo-viscose fiber blend. It covers the arch, heel, and the lower portion of the ankle, and stops just above the ankle bone. There is no graduated compression grade printed on the label — a point the brand's own FAQ addresses by explaining that compression is adjusted by sizing, not by a labeled mmHg rating. For readers coming from a clinical-grade graduated stocking (15–20 mmHg or 20–30 mmHg), that is a material difference and worth flagging up front.

The design has three things going for it that come up repeatedly in verified reviews on the brand's own storefront and in third-party review aggregators:

No straps, Velcro, or fasteners. The sleeve stretches and pulls on. For readers with arthritis in the hands or limited grip strength, this is the single feature mentioned most often as a reason to prefer it over wrap-style braces.
Open-toe. Readers can wear it under a sock or with sandals, and it does not interfere with toe mobility — a frequent complaint about fully enclosed compression socks worn at night.
Washable, no special care. Machine wash cold, air dry. The bamboo fiber the brand uses holds its shape through repeated wash cycles better than the generic nylon-spandex blend used in most $15 drugstore ankle sleeves.

Available colors are gray, black, navy, red, cream, and pink. Sizes run small through 2XL with a wide-fit option for readers with thicker calves. Pricing on the manufacturer's direct storefront is $49.00 for a single pair; multi-pair bundles and seasonal promotions cycle on and off the site. Free US shipping begins at $95 in cart.

Who OneCompress says it's forThe Six Foot-and-Ankle Conditions on the Brand's Own Marketing

Below are the six conditions the brand explicitly markets for on its product page. We are listing them so a reader can see — in one place, without hunting through the brand's own site — exactly what OneCompress itself says the sleeve is intended to help with. None of these are claims of treatment, cure, or reversal. The brand's language is about relief, comfort, and support, and this review carries that same language forward.†

Plantar Fasciitis

Arch support and all-day cushioning for the heel-to-arch band.

Peripheral Neuropathy

Light compression for daily foot discomfort associated with nerve-related sensations.

Diabetic Foot Care

Soft, non-binding fit without pressure cuffs. A clinician's input is still the first step.

Heel Pain & Heel Spurs

Cushioned coverage over the heel bone and the plantar surface.

Arthritis & Joint Stiffness

Warm, gentle hold around the ankle joint for morning stiffness.

Edema & Swelling

All-day comfort for mild foot and ankle fluid retention. Not a substitute for medical graduated compression.

Where a reader should stop and talk to a clinician first

For readers with diabetes, documented peripheral artery disease, lymphedema, open wounds or ulcers on the foot, or any condition that has been prescribed a specific class of medical compression, a slip-on bamboo sleeve is not a substitute for that prescription. Talk to the clinician who manages the condition before adding or substituting anything.

The material · What bamboo-blended fiber actually doesSoft, Breathable, Antimicrobial — and Three Claims That Are Smaller Than They Sound

The OneCompress sleeve in black, shown from the side on a plain studio background — The sleeve ships in six colors. Black and gray are the two the brand lists as most-ordered.

The brand's material claims are worth reading carefully. Bamboo-based textiles have a real set of properties that explain why they feel better than cotton on a 10-hour wear window. They also have a set of marketing claims that get larger than the published literature on the fiber supports.

Base Fiber: Bamboo-viscose blended with spandex for stretch. Soft hand, good drape, retains shape through repeated wash cycles.
Moisture Handling: Bamboo-viscose moves moisture off the skin more quickly than untreated cotton — a real property, well-documented. The brand's claim of "4× cotton" is at the upper end of what the published literature supports.
Antimicrobial: Bamboo fiber retains some of its native antimicrobial properties through processing. "Prevents odor" is a reasonable practical outcome; "antibacterial" as a drug claim is not supported.
Temperature: Breathable, with good thermal regulation for a sleeve worn under socks or around the house. Not meaningfully different from a quality merino blend in a similar weight.
Compression Grade: Not labeled. Not a medical-grade graduated compression stocking. Compression is adjusted by sizing down, which is a user decision, not a prescription.

The honest summary: the fiber choice is a real reason to prefer the OneCompress sleeve over a generic nylon-spandex ankle sleeve at the same price. It is not a reason to prefer it over a clinical-grade graduated stocking for a reader whose clinician has prescribed one.

The thirty-day trial · What a daily wear window actually looked likeOne Pair, Worn Daily, Thirty Days, Three Readings

A plain notebook and pen on a wooden desk — the thirty-day comfort-and-wear log the review is built around — The log the review relies on is low-tech on purpose: a comfort score at wake, mid-day, and bedtime. Thirty days.

A sleeve without a routine is a drawer item. The point of running the thirty days is not to prove the sleeve "works" — it is to give a reader a comparable, honest read of their own daily comfort, before and after. The routine that produced this review is deliberately low-tech, and any reader can reproduce it with a $0.00 pencil-and-paper log.

Days 1–7Baseline

Record a baseline before the first wear

For seven consecutive days before the sleeves arrive, write down a 1-to-10 foot-comfort score three times a day: at wake, mid-day, and bedtime. Note what each day looked like — walking, sitting, cooking, errands. Discard day one; average days two through seven for a baseline number.

Day 8First wear

Put the sleeves on, size down one if in doubt

The brand's own sizing guidance is to size down for more hold, size up for a wider fit. For a first pair, their mid-size is a reasonable starting point. Pull on in the morning. Wear through the day. Remove at bedtime.

Days 8–21Daily routine

Change nothing else

Not shoes, not walking distance, not evening routine. Any parallel change becomes a confound. Keep the three-reading log going. Note anything the sleeve does well (ease of putting on, stays in place, doesn't pinch) and anything it does poorly (bunching, hot spots, loss of stretch).

Days 22–30Overnight trial

Try wearing them overnight (optional)

The brand markets daytime and overnight wear. Some readers find the overnight hold useful for morning stiffness; others find any sock-weight item uncomfortable at night. Nine days is enough to decide.

Day 30Decision

Compare the average to the baseline week

If the average comfort score has moved in a direction and magnitude that matters, keep the pair. If it is flat, the 60-day guarantee covers the return — this is the window the manufacturer themselves ask readers to use.

Three things it will not doThe Honest Limits, Before the Purchase

It will not treat, cure, or reverse peripheral neuropathy or any other diagnosed condition. Nothing on the label asks it to. Any change to a treatment plan is a conversation with the clinician managing the condition — not a decision a consumer makes alone, and never one based on a product review.†
It will not deliver a prescription-grade compression dose. There is no mmHg rating on the label. For a reader whose clinician has written a graduated-compression prescription, this is not that product and should not be used as a substitute.
It will not survive the dryer. The brand's own washing guidance is machine wash cold and air dry. A reader who tumble-dries will shorten the useful life of the fiber meaningfully.

Who it suits · Who it does notTwo Short Lists, No Hedging

The OneCompress Bamboo Footsleeve in navy, shown from the side — The navy version is one of six colors the brand ships.

It suits

Adults on their feet most of the day — teachers, nurses, retail staff, walkers — looking for an added layer of all-day comfort at the arch and ankle.
Readers with arthritis in the hands who find wrap-style braces difficult to fasten.
Readers who want an open-toe sleeve they can wear with sandals, under socks, or around the house.
Readers who prefer a bamboo-blended fabric over nylon-spandex for softness and breathability on a long wear window.
Buyers who are comfortable using a 60-day return window on an opened pair as insurance on a $49 trial.

It does not suit

Adults with a prescription for a specific class of medical-grade graduated compression stocking.
Adults with open wounds, ulcers, or active skin infections on the foot — any sleeve should wait for a clinician's input.
Readers managing diabetes, peripheral artery disease, or lymphedema who have not run the question past the clinician who manages that condition.
Readers looking for a surgical-recovery device. This is not that category.

Where it is sold · The return mathDirect From OneCompress · 60-Day Risk-Free Money-Back Guarantee

A plain kitchen table with a mug and a notebook — the editorial recap setting used throughout this review — OneCompress is a direct-to-consumer brand based in the United States; US orders ship from Springfield, Missouri.

The sleeve is sold direct-to-consumer by OneCompress, a US-designed brand that ships US orders from Springfield, Missouri. Pricing on the manufacturer's storefront is $49.00 for a single pair, with multi-pair bundles that drop the per-pair price on the brand's own promotional pages. Free US shipping begins at $95 in cart. Delivery estimates are 2–5 business days for most US orders once shipped.

The part of OneCompress's policy that carries the cost of trying a new sleeve is worth reading in the manufacturer's own words before the purchase: the 60-day risk-free guarantee covers an opened pair for a full refund if the reader does not experience less foot discomfort and better mobility. Shipping is not refunded; the price of the product is. For sizing errors, OneCompress's FAQ says the company sends a replacement pair rather than requiring a full return. Read the current policy on the manufacturer's page linked in the sidebar; terms do change.

Not medical advice · A standing reminder

Nothing in this review is medical guidance, a diagnosis, or a prescription. Statements made about this product have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease, including peripheral neuropathy. Individual results vary. If a reader takes a prescription medication, is managing a diagnosed foot or circulatory condition, or has been prescribed a specific class of medical compression, the responsible step is a conversation with a licensed clinician before starting this or any new wearable.†

Reader notesComments From Readers of an Earlier Version of This Review

Comments below were received by email after an earlier draft of this review circulated in September. Each is quoted with the writer's permission; last names and cities have been shortened at the writer's request. Individual outcomes described in reader comments are personal experiences only — they are not clinical results, have not been independently verified, and should not be expected by a new reader.

Irma R. verified emailRound Rock, TX · 60s

★★★★☆

"I kept the three-reading log you described, which I would not have done on my own. The mid-day score moved up over three weeks. The pair stays on all day without me thinking about it, which is the real reason I will reorder."

Margie A. verified emailGrand Rapids, MI · 70s

★★★★★

"I liked that the review was clear about what the sleeve would not do. I bought two pairs so I can wash one and wear one. The fit is roomier than I expected; I will size down on my next order."

Marcy P. verified emailPortland, OR · 60s

★★★☆☆

"Flat log at day thirty and I returned the pair. OneCompress honored the refund without a back-and-forth, which was the part of this review I most wanted to verify. Took eight days for the refund to clear."

Ms. R. G. verified emailBrooklyn, NY · 40s

★★★★☆

"I bought a pair for my mother. She has arthritis in her hands and the strapless design was the specific reason she agreed to try them. She wears them around the house most days now; she has not changed any medication and would not without her doctor."

Sabrina L. verified emailCharleston, SC · 60s

★★★★☆

"I bought the gray and the navy. I like that there is no Velcro to catch on the sheets at night. The fiber held up through about eight weeks of daily wash so far; I will update the review in another month."

Common questions · Short answersWhat Readers Email Us Most Often About This Product

Is this a medical device?

No. The OneCompress Bamboo Footsleeve is a consumer wearable, not a medical device. It does not carry a labeled compression grade (mmHg), and it is not a substitute for a prescription-grade graduated compression stocking.†

Can I sleep in them?

The brand markets both daytime and overnight wear. Some readers find overnight wear helpful for morning stiffness; others prefer removing them at bedtime. Try both and keep the one that stays comfortable eight hours in.

How do I pick a size?

Sizes run small through 2XL with a wide-fit option. The brand's own guidance is to size down for more hold and size up for a wider fit. If the first pair is wrong, OneCompress's FAQ says the company sends a replacement rather than requiring a full return.

Can I wash them?

Yes. Machine wash cold, air dry. Tumble-drying will shorten the useful life of the fiber meaningfully.

What is the return policy?

A 60-day risk-free money-back guarantee is printed on the manufacturer's storefront. Shipping is not refunded; the product price is. Policy terms change — read the current version at the manufacturer link in the sidebar before placing the order.

Read OneCompress's Current Policy, Sizing Chart, and 60-Day Guarantee

The manufacturer's own storefront is where sizing, color availability, bundle pricing, and the current return window are kept up to date. Prices and promotions change; the sidebar link below opens the current list.

$49.00 · single pair · multi-pair bundles available

Read the Manufacturer's Current Offer →

Opens the OneCompress storefront. We may earn a commission on orders placed through this link at no extra cost to the reader.

Not medical advice. Results vary. Statements have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease.†

References & sources

Hicks CW, Selvin E. Epidemiology of Peripheral Neuropathy and Lower Extremity Disease in Diabetes. Curr Diab Rep. 2019;19(10):86. Public overview of the ~20 million US adult figure cited above.
National Institute of Neurological Disorders and Stroke (NINDS). Peripheral Neuropathy Fact Sheet. US National Institutes of Health. Source for the clinical overview, mechanism description, and the length-dependent polyneuropathy pattern.
American Diabetes Association. Standards of Care in Diabetes — Microvascular Complications and Foot Care sections. Source for the diabetes-related neuropathy prevalence range cited above.
England JD, Asbury AK. Peripheral neuropathy. Lancet. 2004;363(9427):2151-61. Classic review covering the small-fiber vs. large-fiber distinction and the sensory/motor/autonomic classification used in the glossary.
Pop-Busui R et al. Diabetic neuropathy: A position statement by the American Diabetes Association. Diabetes Care. 2017;40(1):136-154. Source for the published evidence on glycemic control and exercise.
Ziegler D et al. Treatment of symptomatic diabetic peripheral neuropathy with the antioxidant α-lipoic acid: SYDNEY 2 trial. Diabetes Care. 2006. Source for the alpha-lipoic acid note.
OneCompress. Premium Anti-Fatigue Bamboo Footsleeves — product page. onecompress.com/products/bamboofootsleeves. Accessed Oct 2026. Source for the material description, color/size list, 60-day guarantee language, and the six marketed-for conditions.
OneCompress. FAQ and Shipping Info pages. Accessed Oct 2026. Source for sizing guidance, replacement policy, and washing instructions.